title: Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control.
abstract: BACKGROUND
  National data find glycemic control is within target (A1c<7.0%) for 37% of patients with diabetes, and only 7% meet recommended glycemic, lipid, and blood pressure goals.
  
  
  OBJECTIVE
  To compare active interventions and usual care for glucose control in a randomized clinical trial (RCT) among persons with diabetes cared for by primary care physicians (PCPs) over the course of 1 year.
  
  
  METHODS
  Physician practices (n=36) in 4 geographic areas are randomly assigned to 1 of 4 study groups. The intervention is a diabetes communication system, using mobile phones and patient/physician portals to allow patient-specific treatment and communication. All physicians receive American Diabetes Association (ADA) Guidelines for diabetes care. Patients with poor diabetes control (A1c> or =7.5%) at baseline (n=260) are enrolled in study groups based on PCP randomization. All study patients receive blood glucose (BG) meters and a year's supply of testing materials. Patients in three treatment groups select one of two mobile phone models, receive one-year unlimited mobile phone data and service plan, register on the web-based individual patient portal and receive study treatment phone software based on study assignment. Control group patients receive usual care from their PCP. The primary outcome is mean change in A1c over a 12-month intervention period.
  
  
  CONCLUSIONS
  Traditional methods of disease management have not achieved adequate control for BG and other conditions important to persons with diabetes. Tools to improve communication between patients and PCPs may improve patient outcomes and be satisfactory to patients and physicians. This RCT is ongoing.
authors.affiliation: Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 660 W. Redwood Street, Baltimore, MD 21201, United States. cquinn@epi.umaryland.edu
authors.forename: Charlene C
authors.initials: CC
authors.lastname: Quinn
authors.forename: Ann L
authors.initials: AL
authors.lastname: Gruber-Baldini
authors.forename: Michelle
authors.initials: M
authors.lastname: Shardell
authors.forename: Kelly
authors.initials: K
authors.lastname: Weed
authors.forename: Suzanne S
authors.initials: SS
authors.lastname: Clough
authors.forename: Malinda
authors.initials: M
authors.lastname: Peeples
authors.forename: Michael
authors.initials: M
authors.lastname: Terrin
authors.forename: Lauren
authors.initials: L
authors.lastname: Bronich-Hall
authors.forename: Erik
authors.initials: E
authors.lastname: Barr
authors.forename: Dan
authors.initials: D
authors.lastname: Lender
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D015992:Body Mass Index; D040421:Cell Phone; D003142:Communication; D015897:Comorbidity; D003863:Depression / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy* / Q000453:epidemiology; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians'; D015995:Prevalence; D012042:Registries; D020377:Self Efficacy
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents